TH1601000305A - Glyoxamide-substituted pyrrolamide derivatives and the use of that as medicine for treating hepatitis B - Google Patents

Glyoxamide-substituted pyrrolamide derivatives and the use of that as medicine for treating hepatitis B

Info

Publication number
TH1601000305A
TH1601000305A TH1601000305A TH1601000305A TH1601000305A TH 1601000305 A TH1601000305 A TH 1601000305A TH 1601000305 A TH1601000305 A TH 1601000305A TH 1601000305 A TH1601000305 A TH 1601000305A TH 1601000305 A TH1601000305 A TH 1601000305A
Authority
TH
Thailand
Prior art keywords
glyoxamide
medicine
treating hepatitis
substituted
derivatives
Prior art date
Application number
TH1601000305A
Other languages
Thai (th)
Other versions
TH181125A (en
Inventor
แวนดิกค์ปีแอร์ ฌอน มารี เบอร์นาด ราบัวซ์ซันบาร์ท รูดอล์ฟ โรมานี เคสเทลีนเกียร์ท รอมบูทส์เซิร์จ มาเรีย เอลอยเซียส ปีเตอร์สเวิร์สชูเอเรน วิม กาสตัน โคเอน
Original Assignee
แจนส์เซน ไซเอนเซส ไอร์แลนด์ ยูซี
Filing date
Publication date
Application filed by แจนส์เซน ไซเอนเซส ไอร์แลนด์ ยูซี filed Critical แจนส์เซน ไซเอนเซส ไอร์แลนด์ ยูซี
Publication of TH1601000305A publication Critical patent/TH1601000305A/en
Publication of TH181125A publication Critical patent/TH181125A/th

Links

Abstract

; ;

TH1601000305A 2014-07-25 Glyoxamide-substituted pyrrolamide derivatives and the use of that as medicine for treating hepatitis B TH1601000305A (en)

Publications (2)

Publication Number Publication Date
TH1601000305A true TH1601000305A (en) 2018-11-01
TH181125A TH181125A (en) 2018-11-01

Family

ID=

Similar Documents

Publication Publication Date Title
IL272820A (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
DK3521282T3 (en) QUINAZOLINE DERIVATIVES USED FOR THE TREATMENT OF HIV
IL246678A0 (en) Azepane derivatives and methods of treating hepatitis b infections
EP3240787A4 (en) Derivatives and methods of treating hepatitis b infections
DK3102673T3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF BETA-TALASSEMI
DK3134530T3 (en) TREATMENT OF HYPERBILIR RUBINY
DK3362066T3 (en) COMBINATION THERAPY FOR THE TREATMENT OF MALIGNITIES
DK3481846T3 (en) 11-SUBSTITUTED 24-HYDROXYSTEROLS FOR USE IN THE TREATMENT OF NMDA-RELATED CONDITIONS
DK3240612T3 (en) PROCEDURES FOR THE TREATMENT OF RHINTH DISEASES
DK3099298T3 (en) COMBINATION THERAPIES WITH ZIDOVUDIN FOR TREATMENT OF MICROBIBLE INFECTIONS
BR112016022976A2 (en) METHODS FOR THE TREATMENT OF HCV
HK1231402A1 (en) Methods for the treatment of hepatitis b and hepatitis d virus infections b d
DK3302478T3 (en) PAC-1 COMBINATION TREATMENT
FI20145633A (en) Procedure for the treatment of biosludge
DK3157532T3 (en) PROCEDURES FOR THE TREATMENT AND PREVENTION OF DISEASES WITH VASCULAR INSTABILITY
DK3164123T3 (en) Novel uses of benzylideneguanidine derivatives in the treatment of proteopathies
DK3200783T3 (en) TREATMENT OF ERYTROMELALGY
KR20180084983A (en) Uses of Pyrimido-Pyrimidazinone for the Treatment of Cancer
TH1601000305A (en) Glyoxamide-substituted pyrrolamide derivatives and the use of that as medicine for treating hepatitis B
TH1601002131A (en) Carboxamic derivatives and its use as medicine for the treatment of hepatitis B
TH1601001266A (en) Methods and pharmaceutical compositions for the treatment of hepatitis B infection.
TH1601000571A (en) Compounds showing medicinal effects and methods of their use
TH1501006820A (en) Sulfamoylpyrrolamide derivatives and their uses It is a drug for the treatment of hepatitis B.
TH1601002905A (en) Methods and components for targeted modification of the genome.
TH1501005877A (en) Composition and methods for increasing the stability of microorganisms